Transform lengthy academic papers into concise, structured 250-word abstracts.
日本語の概要は準備中です。原文の説明を表示しています。
Prepare FDA/EMA regulatory submissions (IND/NDA/BLA/510(k)/PMA/MAA) in CTD format. Generate module outlines (Modules 1-5), run ICH compliance checks (ALCOA+, E6 GCP, Q1-Q12), verify data integrity, and produce submission-ready dossiers with cover letters and checklists.
インストールする前に、エージェントに与えられる指示の中身を確認できます。
| Type | Purpose | Key Sections |
|---|---|---|
| IND | Investigational New Drug | Chemistry, pharmacology, toxicology, clinical protocol |
| NDA | New Drug Application | Full CMC, nonclinical, clinical data |
| BLA | Biologics License | Manufacturing, characterization, clinical |
| 510(k) | Device clearance | Substantial equivalence, performance testing |
| PMA | Device approval | Clinical data, manufacturing |
This skill accepts requests that match the documented purpose of regulatory-submission and include enough context to complete the workflow safely.
Do not continue the workflow when the request is out of scope, missing a critical input, or would require unsupported assumptions. Instead respond:
regulatory-submissiononly handles its documented workflow. Please provide the missing required inputs or switch to a more suitable skill.
まだレビューはありません。使ってみた感想をお寄せください。
概要と使いどころ
Transform lengthy academic papers into concise, structured 250-word abstracts.
日本語の概要は準備中です。原文の説明を表示しています。
Precision editing tool that reduces abstract word count through intelligent compression techniques, maintaining scientific rigor while meeting strict journal and conference requirements.
日本語の概要は準備中です。原文の説明を表示しています。
Refines long medical academic texts into SCI-style unstructured Chinese and English abstracts; use when you need to condense drafts/reports/summaries into bilingual abstracts and generate Summary_Report.md.
日本語の概要は準備中です。原文の説明を表示しています。
Generates submission-ready Elsevier/SCI Highlights from manuscript text or extracted PDF/DOCX/TXT content. Use when a user needs 3-5 concise, evidence-grounded highlight bullets for a research paper, review, meta-analysis, case report, or bioinformatics manuscript.
日本語の概要は準備中です。原文の説明を表示しています。
Generates complete FAERS pharmacovigilance study designs for multi-drug or class-level safety comparison inside one predefined SOC or AE family using active comparators, disproportionality analysis, subgroup characterization, and reviewer-facing evidence control.
日本語の概要は準備中です。原文の説明を表示しています。
Analyze data with `adme-property-predictor` using a reproducible workflow, explicit validation, and structured outputs for review-ready interpretation.
日本語の概要は準備中です。原文の説明を表示しています。